For instance, arrayed CRISPR screening has been used to discover factors necessary for cross-presentation of tumor-antigens by conventional DC1s (cDC1s), most notably Wdfy4 (15) (Figure 1A). This evidence concerns the gene WDFY4 and neoplasm.